Krzysztof Brzozka
Chief Tech/Sci/R&D Officer bei RYVU THERAPEUTICS S.A.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Dr. Krzysztof Brzozka is a Chief Scientific Officer & Executive VP at Ryvu Therapeutics SA. He is on the Board of Directors at Ardigen SA. He received his graduate degree from Uniwersytet Jagiellonski, an MBA from Cracow University of Economics, an MBA from Stockholm Business School and a doctorate degree from Ludwig-Maximilians-Universität München.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RYVU THERAPEUTICS SA
1,16% | 31.12.2022 | 267 321 ( 1,16% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Krzysztof Brzozka
| Unternehmen | Position | Beginn |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 17.07.2014 |
Ardigen SA
 Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Director/Board Member | - |
Ausbildung von Krzysztof Brzozka
| Uniwersytet Jagiellonski | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| Cracow University of Economics | Masters Business Admin |
| Stockholm Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ardigen SA
Ardigen SA Packaged SoftwareTechnology Services Ardigen SA is a precision medicine company based in Kraków, Poland. The Polish company specializes in using advanced artificial intelligence methods to accelerate therapy development by decoding microbiome, designing immunity, and providing digital drug discovery services. Ardigen's team has deep expertise in bioinformatics, machine learning, and software engineering, and their in-house datasets and platforms for immunology, biomarker, and microbiome research can empower effective pharmaceuticals development. The private company was founded by Pawel Przewiezlikowski, and the CEO is Janusz Homa. | Technology Services |
